Eledon Pharmaceuticals Statistics
NASDAQ: ELDNHealthcareBiotechnologyUSD
2.42-0.03 (-1.22%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Eledon Pharmaceuticals by the numbers
Eledon Pharmaceuticals has a market capitalization of $196.7 million based on 81.26M shares outstanding. With trailing EPS of $-0.89, Eledon Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.8% below its 50-day average and 20.4% below its 200-day average.
Average daily trading volume is 949.99K shares, or about $2.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ELDN valuation vs. peer median
| Metric | ELDN | Peer median | Difference |
|---|---|---|---|
| Market cap | $196.65M | $199.49M | -1% |
| Avg. volume | 949.99K | 247.07K | +285% |
Peer median across 8 companies: ACOG, RNAC, CGEN, WHWK, ADAG, LYEL, NGEN, ALEC.
Valuation
- Market cap
- $196.65M
- EPS (TTM)
- $-0.89
- Shares outstanding
- 81.26M
Price and trading
- Previous close
- 2.45
- Open
- 2.42
- Day range
- 2.39 – 2.48
- 52-week range
- 1.35 – 4.60
- 52-week change
- -11.36%
- Beta
- —
- Volume
- 581.21K
- Average volume
- 949.99K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 196.65M
- Forward Pe
- -3.14
- Eps
- -0.89
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.60
- Week52 Low
- 1.35
- Avg Volume
- 949.99K
- Shares Outstanding
- 81.26M
- Ma50
- 3.10
- Ma200
- 3.04
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -47.39%
- Pct From52w Low
- 79.26%